Atlas Trials

First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC

Clinical trial NCT04408118 · COMPLETED

Trial details

NCT number
NCT04408118
Sponsor
MedSIR
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast CancerAdvanced Breast CancerTriple Negative Breast Cancer
Start date
2020-10-05
Primary completion
2023-12-07
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.